JPRN-jRCT2080222120未知2 期
DS-7113b phase II study -A DS-7113b potency ratio assessment study in patients with cancer pain.
DAIICHISANKYO Co.,Ltd.0 个研究点开始时间: 2013年6月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with cancer pain whose pain is controlled by steady dose of an oral morphine during the screening period.
- •-Patients whose frequency of rescue dose during the screening period is within the specified number.
- •-Patients with an ECOG PS of =<3, etc.
排除标准
- •Patients with symptom(s)/finding(s) falling under the contraindications or relative contraindications stated in the package insert of oral morphine preparations, etc.
研究者
相似试验
未知
3 期
DS-7113b phase III studyModerate to severe cancer painJPRN-jRCT2080222239DAIICHISANKYO Co.,Ltd.
未知
2 期
DD-723 Phase II clinical trial (Breast)Patients with breast tumorJPRN-jRCT2080220863DAIICHISANKYO Co.,Ltd.75
未知
2 期
DD-723 Phase II clinical trial (Prostate)Patients with suspected prostate cancerJPRN-jRCT2080220862DAIICHISANKYO Co.,Ltd.75
未知
1 期
Phase I study of DS-7113bHealthy volunteersJPRN-jRCT2080222121DAIICHISANKYO Co.,Ltd.30
未知
3 期
DS-7113b phase III studyModerate to severe cancer painJPRN-jRCT2080222289DAIICHISANKYO Co.,Ltd.